Breakthrough in Aluminium Phosphide Poisoning Treatment at PGIMER Chandigarh
Introduction to the Research
Chandigarh: Doctors at the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, have made significant progress in treating poisoning caused by aluminium phosphide, commonly referred to as Celphos. This lethal pesticide poses a serious health risk, and the findings were announced by officials on Sunday.
Details of the Study
The research, conducted by the Department of Internal Medicine at PGIMER, marks the first clinical study to showcase the effectiveness of intravenous lipid emulsion as a novel life-saving therapy for a condition that is typically highly fatal. The important findings have been published in the esteemed journal European Review of Medical and Pharmacological Sciences, earning global recognition for the research.
Leadership and Institutional Support
Dr. Sanjay Jain, Dean (Academics) and Professor and Head of the Department of Internal Medicine at PGIMER, provided clinical leadership that was crucial for managing these critically ill patients. The study was funded by the Medical Education and Research Cell at PGIMER, reflecting the institute’s commitment to supporting clinically relevant and socially impactful research.
Study Leadership and Findings
The randomized clinical study was led by Dr. Mandip Singh Bhatia, Associate Professor of Internal Medicine, who served as the primary investigator. Dr. Saurabh Chandrabhan Sharda acted as the co-investigator, collaborating with other authors from the same department.
The results of the study were highly promising. Patients who received intravenous lipid emulsion alongside standard medical treatment exhibited a significant reduction in mortality rates, accelerated correction of severe metabolic acidosis, improved hemodynamic stability, and better outcomes, particularly in those presenting with shock and cardiac complications.
Impact of Early Administration
The PGIMER statement emphasized that early administration of this therapy could substantially alter the clinical trajectory of aluminium phosphide poisoning.
Practicality of the Treatment
One of the treatment’s major advantages is its practicality. Intravenous lipid emulsion is cost-effective, readily available, and stocked in most hospitals across India, including district hospitals and peripheral healthcare facilities. Its affordability and accessibility position it as a potential life-saving option, especially in rural and remote areas where cases of Celphos poisoning are prevalent, and access to advanced critical care is limited.
Public Health Implications
Aluminium phosphide poisoning remains a significant public health concern, particularly in agricultural states such as Punjab, Haryana, and Uttar Pradesh, which experience the highest disease burden due to the widespread use of this compound as a grain preservative. The availability of an effective, affordable, and evidence-based treatment is crucial for these regions.
Commitment to Research
The statement concluded by underscoring PGIMER’s dedication to research focused on local diseases and populations, highlighting the importance of this groundbreaking study in addressing a pressing health challenge.